A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate
Clinical trial NCT01059773 · COMPLETED
Trial details
- NCT number
- NCT01059773
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.